Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-01

Clinical Trial Update: Diltiazem Hydrochloride Cream for Anal Fissure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating diltiazem hydrochloride cream for chronic anal fissure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride cream (diltiazem hydrochloride)

Snippet

Sponsor: S.L.A. Pharma AG | Conditions: Chronic Anal Fissure | Phase 3 | Status: COMPLETED | Results posted: 2014-07-01